UriLadabaumMD
Gastroenterology • Stanford, CAAssociate Professor, Medicine - Gastroenterology & Hepatology, Stanford University Medical Center
Dr. Ladabaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
University of MichiganFellowship, Gastroenterology, 1995 - 1998
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1991 - 1995
University of California San Francisco School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1992 - 2026
MI State Medical License 1998 - 2002
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Citalopram in Irritable Bowel Syndrome Start of enrollment: 2001 Apr 01
- Does Knowing One's Estimated Colorectal Cancer Risk Influence Screening Behavior? Start of enrollment: 2015 Oct 06
- Outreach and Choice in Colorectal Cancer Screening Start of enrollment: 2021 Aug 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 314 citationsRacial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood CharacteristicsLibby Ellis, Alison J. Canchola, David Spiegel, Uri Ladabaum, Robert W. Haile
Journal of Clinical Oncology. 2018-01-01 - 170 citationsAdvanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis.Frank W. Chen, Vandana Sundaram, Thomas A. Chew, Uri Ladabaum
Clinical Gastroenterology and Hepatology. 2017-05-01 - 2 citationsGlobal loss of promoter-enhancer connectivity and rebalancing of gene expression during early colorectal cancer carcinogenesis.Yizhou Zhu, Hayan Lee, Shannon White, Annika K Weimer, Emma Monte
Nature Cancer. 2024-10-30
Journal Articles
- Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. MedicareJoel V Brill, Uri Ladabaum, Nature
Press Mentions
Cell-Free Blood DNA Tests Less Effective Than Other CRC ScreeningOctober 31st, 2024- New Colorectal Cancer Blood Tests Not as Effective as ColonoscopyOctober 29th, 2024
- Stanford Study Reveals Blood Tests for Colon Cancer Fall Short of Colonoscopy EffectivenessOctober 28th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
